Biodexa Pharmaceuticals BDRX
NASDAQ BDRX
$0.81 -0.02 (-2.24%)
At close: Sep 9, 2026 · 4:00 PM EDT

Biodexa Pharmaceuticals (BDRX) Operating Leases (2018 - 2025)

Biodexa Pharmaceuticals' (BDRX) quarterly Operating Leases came in at $81140.1 in Q4 2025, down 64.68% year-over-year from $229746.8 in Q4 2024, and down 64.68% quarter-over-quarter from $229746.8 in Q4 2024.

Analysis

Biodexa Pharmaceuticals (BDRX) Operating Leases (2018 - 2025) Analysis & Trends

Biodexa Pharmaceuticals has disclosed Operating Leases across 8 years of filings, most recently posting $81140.1 for Q4 2025.

  • In Q4 2025, Operating Leases fell 64.68% year-over-year to $81140.1; the TTM figure through Dec 2025 stood at $81140.1 (down 64.68% YoY), while the FY2025 annual figure was $80429.1, down 64.85% from the prior year.
  • Operating Leases came in at $81140.1 for Q4 2025 at Biodexa Pharmaceuticals, down from $229746.8 in the prior quarter.
  • In the past five years, Operating Leases ranged from a high of $745449.9 in Q4 2021 to a low of $81140.1 in Q4 2025.
  • Average Operating Leases over 5 years is $290986.6, with a median of $209754.7 recorded in 2023.
  • Year-over-year, Operating Leases plunged 74.67% in 2022 and gained 11.07% in 2023.
  • Over 5 years, Operating Leases stood at $745449.9 in 2021, then sank by 74.67% to $188841.5 in 2022, then climbed by 11.07% to $209754.7 in 2023, then rose by 9.53% to $229746.8 in 2024, then sank by 64.68% to $81140.1 in 2025.
  • Per Business Quant data, the three most recent Operating Leases figures were $81140.1 in Q4 2025, $229746.8 in Q4 2024, and $209754.7 in Q4 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 236.37 Bn 222.38 Bn 7.24 Bn
2 Gilead Sciences 187.38 Bn 184.12 Bn 6.22 Bn
3 Vertex Pharmaceuticals 138.36 Bn 130.51 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 85.09 Bn 77.10 Bn 3.93 Bn
5 Argenx Se 63.93 Bn 58.75 Bn 1.37 Bn
6 Moderna 58.07 Bn 52.94 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 35.59 Bn 32.28 Bn 992.69 Mn
8 Biogen 32.63 Bn 31.34 Bn 1.96 Bn
9 Insmed 27.57 Bn 26.41 Bn 358.27 Mn
10 Biodexa Pharmaceuticals 53.69 Mn 42.34 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 81,140.14
Dec 31, 2024 229,746.83
Dec 31, 2023 209,754.67
Dec 31, 2022 188,841.46
Dec 31, 2021 745,449.87
Dec 31, 2020 2.06 Mn
Dec 31, 2019 853,721.34
Dec 31, 2018 321,691.81